Unique ID issued by UMIN | UMIN000005523 |
---|---|
Receipt number | R000006548 |
Scientific Title | Effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease. |
Date of disclosure of the study information | 2011/04/28 |
Last modified on | 2011/05/09 13:51:11 |
Effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease.
Carotid Atherosclerosis- Antihypertensive Treatment Trial, Effect of N-type CCB for cerebrovascular Disease (CA-ATTEND).
Effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease.
Carotid Atherosclerosis- Antihypertensive Treatment Trial, Effect of N-type CCB for cerebrovascular Disease (CA-ATTEND).
Japan |
Essential Hypertension
Medicine in general | Cardiology | Neurology |
Others
NO
To study effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Change in blood pressure levels
Adverse events, changes of atherosclerosis indices.
Observational
Not applicable |
Not applicable |
Male and Female
Atelec-naive patients with essential hypertension and cerebrovascular disease.
Pregnant or possibly pregnant patients.
3000
1st name | |
Middle name | |
Last name | Masayasu Matsumoto |
Hiroshima University
Department of Clinical Neuroscience and Therapeutics, Division of Integrated Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences
1-2-3, Kasumi, Minami-ku, Hiroshima 734-0037, Japan
082-257-5201
1st name | |
Middle name | |
Last name | Eiichi Ohara |
Mochida Pharmaceutical Co., Ltd.
Post-Marketing Surveillance
1-7 Yotsuya, Shinjyuku-ku, Tokyo 160-8515 Japan
03-3225-6342
atelec.ms.tokutei@mochida.co.jp
Ajinomoto Pharmaceuticals Co., LTD.
Mochida Pharmaceutical Co., Ltd.
Profit organization
NO
2011 | Year | 04 | Month | 28 | Day |
Unpublished
Open public recruiting
2011 | Year | 03 | Month | 17 | Day |
2011 | Year | 05 | Month | 01 | Day |
2014 | Year | 03 | Month | 01 | Day |
This study is conducted prospectively and observationally. Patients are registered by the Patient Registration Center System.
2011 | Year | 04 | Month | 28 | Day |
2011 | Year | 05 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006548
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |